HRP20050040A2 - Stabilization of the profile of release of active supstances from a formulation - Google Patents
Stabilization of the profile of release of active supstances from a formulationInfo
- Publication number
- HRP20050040A2 HRP20050040A2 HR20050040A HRP20050040A HRP20050040A2 HR P20050040 A2 HRP20050040 A2 HR P20050040A2 HR 20050040 A HR20050040 A HR 20050040A HR P20050040 A HRP20050040 A HR P20050040A HR P20050040 A2 HRP20050040 A2 HR P20050040A2
- Authority
- HR
- Croatia
- Prior art keywords
- formulation
- profile
- active
- supstances
- stabilization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Izum navodi postupak za prethodnu fizikalnu obradu aktivne supstance kojim se modificiraju tehnološki važna fizikalna svojstva aktivne supstance, tako omogućivši pripravu formulacije koja ima stabilniji profil oslobađanja aktivne supstance tijekom cijelog roka valjanosti lijeka nego što bi to bio profil s istim sastavom, ali bez prethodne obrade.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200200179A SI21256A (sl) | 2002-07-17 | 2002-07-17 | Stabilizacija profila sproščanja učinkovin iz formulacije |
PCT/SI2003/000025 WO2004006888A2 (en) | 2002-07-17 | 2003-07-15 | Stabilization of the profile of release of active substances from a formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20050040A2 true HRP20050040A2 (en) | 2006-11-30 |
Family
ID=30113493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20050040A HRP20050040A2 (en) | 2002-07-17 | 2005-01-14 | Stabilization of the profile of release of active supstances from a formulation |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060083759A1 (hr) |
EP (1) | EP1524965A2 (hr) |
AU (1) | AU2003248615B2 (hr) |
HR (1) | HRP20050040A2 (hr) |
PL (1) | PL372771A1 (hr) |
RS (1) | RS20050038A (hr) |
RU (1) | RU2354387C2 (hr) |
SI (1) | SI21256A (hr) |
UA (1) | UA89020C2 (hr) |
WO (1) | WO2004006888A2 (hr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2283824B1 (en) * | 2009-07-30 | 2017-04-19 | Special Products Line S.p.A. | Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin |
CN108853039B (zh) * | 2018-08-07 | 2021-03-09 | 河北君临药业有限公司 | 一种克拉霉素分散片及其生产工艺 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1236023A (en) * | 1984-07-18 | 1988-05-03 | Yegnaswami Raghunathan | Controlled release pharmaceutical preparations |
GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US5009895A (en) * | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
CA2039742A1 (en) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Tablet composition and method for problem pharmaceutical materials |
US5599556A (en) * | 1991-12-31 | 1997-02-04 | Abbott Laboratories | Prolamine coatings for taste masking |
US5919489A (en) * | 1995-11-01 | 1999-07-06 | Abbott Laboratories | Process for aqueous granulation of clarithromycin |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
SI20150A (sl) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina |
ATE338053T1 (de) * | 2000-03-15 | 2006-09-15 | Hanmi Pharm Ind Co Ltd | Verfahren zur herstellung von clarythromycin mit nicht pharmazeutischer qualität |
US6899890B2 (en) * | 2002-03-20 | 2005-05-31 | Kv Pharmaceutical Company | Bioadhesive drug delivery system |
-
2002
- 2002-07-15 US US10/521,295 patent/US20060083759A1/en not_active Abandoned
- 2002-07-17 SI SI200200179A patent/SI21256A/sl not_active IP Right Cessation
-
2003
- 2003-07-15 EP EP03764288A patent/EP1524965A2/en not_active Withdrawn
- 2003-07-15 WO PCT/SI2003/000025 patent/WO2004006888A2/en not_active Application Discontinuation
- 2003-07-15 AU AU2003248615A patent/AU2003248615B2/en not_active Ceased
- 2003-07-15 RS YUP-2005/0038A patent/RS20050038A/sr unknown
- 2003-07-15 PL PL03372771A patent/PL372771A1/xx not_active Application Discontinuation
- 2003-07-15 UA UAA200500254A patent/UA89020C2/ru unknown
- 2003-07-15 RU RU2005104423/15A patent/RU2354387C2/ru not_active IP Right Cessation
-
2005
- 2005-01-14 HR HR20050040A patent/HRP20050040A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1524965A2 (en) | 2005-04-27 |
WO2004006888A2 (en) | 2004-01-22 |
RU2005104423A (ru) | 2006-01-27 |
RU2354387C2 (ru) | 2009-05-10 |
AU2003248615B2 (en) | 2006-11-16 |
US20060083759A1 (en) | 2006-04-20 |
RS20050038A (en) | 2007-06-04 |
WO2004006888A3 (en) | 2004-04-29 |
PL372771A1 (en) | 2005-08-08 |
AU2003248615A1 (en) | 2004-02-02 |
UA89020C2 (ru) | 2009-12-25 |
SI21256A (sl) | 2004-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120994T1 (el) | Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων | |
PA8840801A1 (es) | Derivaos de dioxa-biciclo[3.2.1]octano-2,3,4-triol | |
ECSP066302A (es) | Omega-carboxiaril-difenil-urea sustituida con flúor para el tratamiento y la prevención de enfermedades y afecciones | |
WO2020083971A3 (en) | New anthelmintic compounds | |
CL2008003486A1 (es) | 6-oxo-1,6-dihidropiridazinas; sus usos para tratar un trastorno hiperproliferativo; la composición farmacéutica que las contiene; y sus procesos de preparación (div. sol. 1168-06). | |
MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
MY154869A (en) | Composition for treating metabolic syndrome | |
CR8402A (es) | Indazol-o-glucosidos sustitutos | |
BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase | |
TN2009000199A1 (en) | Heteromonocyclic compound and use thereof | |
ATE430743T1 (de) | Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken | |
MX2010002285A (es) | Combinaciones de principios activos con propiedades insecticidas y acaricidas. | |
BRPI0813450B8 (pt) | composto, formulação farmacêutica, e, usos do composto | |
GT200100183A (es) | Derivados de quinolina y quinazolina. | |
CL2009000906A1 (es) | Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas. | |
RS53236B (en) | BETA-AMYLOIDOSIS PEPTIDES | |
UA86599C2 (en) | Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides | |
RU2012157473A (ru) | Способ выявления или лечения реакции "трансплантат против хозяина" | |
CL2008003472A1 (es) | Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias. | |
AR039936A1 (es) | Formulacion farmaceutica de liberacion modificada | |
PH12020551076A1 (en) | Methods for treating diabetes, hepatitis, and/or inflammatory liver disease | |
PL376176A1 (en) | Solid preparation | |
GEP20135959B (en) | Aryl piperazine and their usage as alpha2c antagonists | |
PH12019500808A1 (en) | Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof | |
HRP20050040A2 (en) | Stabilization of the profile of release of active supstances from a formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090713 Year of fee payment: 7 |
|
OBST | Application withdrawn |